Nerve Degeneration
Recent clinical, regulatory, research and industry developments relating to this disease.
An integrative systems-biology approach defines mechanisms of Alzheimer's disease neurodegeneration.
Energy Metabolism and Brain Aging: Strategies to Delay Neuronal Degeneration.
The necroptosis cell death pathway drives neurodegeneration in Alzheimer's disease.
Molecular Mechanisms Associated with Neurodegeneration of Neurotropic Viral Infection.
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
- Active recent publication activity.
Research HighlightsViewHide
- 2025-10-22ResearchShort-Chain Fatty Acids as a Therapeutic Strategy in Parkinson's Disease: Implications for Neurodegeneration.Ravi A · 2025
Research activity
Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.
Major themes8
- Nerve Degeneration8
- Neurodegenerative Diseases3
- Parkinson Disease3
- Aging2
- Alzheimer Disease2
- Brain2
- Mutation2
- Neurons2
Leading journals6
- Acta neuropathologica3
- The Journal of neuroscience : the official journal of the Society for Neuroscience3
- Annual review of neuroscience2
- Cellular and molecular neurobiology2
- Molecular neurobiology2
- Aging cell1
Leading researchers8
- Alosco ML1
- Alvarez VE1
- Alvarez-Fischer D1
- Ansari A1
- Aytan N1
- Balusu S1
- Barck KH1
- Benetatos J1
Affiliations (unnormalised)6
- Harvard Medical School2
- Massachusetts Institute of Technology2
- Acupuncture and Chronobiology Key Laboratory of Sichuan Province1
- Adrienne Helis Malvin Medical Research Foundation1
- and Howard Hughes Medical Institute1
- APDA Center for Advanced Parkinson's Disease Research1
Disease biology
Key proteins & gene products studied in this disease. Number shows shared papers.
Related conditions
Diseases frequently studied alongside this one. Number shows shared papers.
Disease profile
A grounded synthesis of the condition — overview, causes, mechanism, risk factors and current standard of care.
Nerve degeneration is the loss of functional activity and trophic integrity of nerve axons and their terminal branches after destruction of the cell of origin or interruption of continuity with that cell. It is a pathological process characteristic of neurodegenerative diseases and is also studied in relation to neuroanatomical localization and neural pathway function. The literature grounding links it broadly to neuronal injury and degeneration rather than to a single disease entity.
The supplied grounding does not support a single established cause for nerve degeneration as a general entity. It is described as occurring after destruction of the neuron of origin or interruption of axonal continuity, and the literature also associates neurodegenerative pathology with aging, oxidative stress, disturbed energy metabolism, protein aggregation, and inflammatory or endotoxin-related processes. These are presented as contributors to neurodegeneration rather than as a definitive aetiology for all nerve degeneration.
The pathology involves degeneration of axons and their terminal arborizations following loss of trophic support from the parent cell or disruption of axonal continuity. In the supplied reviews, neurodegenerative injury is linked to impaired calcium homeostasis, oxidative stress, energy-metabolic failure, cell death, mitochondrial dysfunction, inflammation, and aggregation of proteins such as tau, alpha-synuclein, and amyloid beta. These processes are described as promoting synaptic dysfunction, neuronal injury, and spread of pathological protein assemblies in some disorders.
Aging is a recurring factor associated with neurodegenerative pathology in the supplied grounding. Other factors linked to increased vulnerability include oxidative stress, impaired energy metabolism, mitochondrial stress, inflammation, and exposure to endotoxin-related inflammatory states. The grounding also notes regional neuronal vulnerability in Parkinson's disease, particularly among dopamine neurons with high bioenergetic demand and extensive axonal networks.
AI-generated summary grounded in MeSH and 6 peer-reviewed sources. Informational only — not medical advice. Generated 2026-07-07.
Reference
Authoritative identity, definition & identifiers.
Loss of functional activity and trophic degeneration of nerve axons and their terminal arborizations following the destruction of their cells of origin or interruption of their continuity with these cells. The pathology is characteristic of neurodegenerative diseases. Often the process of nerve degeneration is studied in research on neuroanatomical localization and correlation of the neurophysiology of neural pathways.
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
- Related entities are derived from literature co-mention (studied together) — associative, not causal.